Oppenheimer & Co. Inc. Acquires 45,088 Shares of Oscar Health, Inc. (NYSE:OSCR)

Oppenheimer & Co. Inc. lifted its holdings in Oscar Health, Inc. (NYSE:OSCR) by 175.3% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 70,806 shares of the company’s stock after purchasing an additional 45,088 shares during the period. Oppenheimer & Co. Inc.’s holdings in Oscar Health were worth $1,502,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Victory Capital Management Inc. lifted its holdings in Oscar Health by 42.4% during the third quarter. Victory Capital Management Inc. now owns 58,353 shares of the company’s stock worth $1,238,000 after buying an additional 17,377 shares during the period. Aigen Investment Management LP acquired a new stake in Oscar Health in the third quarter valued at approximately $205,000. Versor Investments LP purchased a new position in Oscar Health in the third quarter worth $787,000. GDS Wealth Management acquired a new position in shares of Oscar Health during the third quarter worth $446,000. Finally, Los Angeles Capital Management LLC acquired a new stake in shares of Oscar Health in the 3rd quarter worth $627,000. 75.70% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have commented on OSCR. UBS Group assumed coverage on Oscar Health in a research note on Monday, October 7th. They issued a “neutral” rating and a $23.00 price target for the company. Bank of America lowered shares of Oscar Health from a “neutral” rating to an “underperform” rating and decreased their price objective for the company from $21.00 to $13.50 in a research report on Wednesday, November 6th. Finally, Piper Sandler restated an “overweight” rating and set a $28.00 price target on shares of Oscar Health in a research note on Tuesday, September 10th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $22.93.

Oscar Health Price Performance

Shares of NYSE:OSCR opened at $14.87 on Monday. The company has a current ratio of 0.73, a quick ratio of 0.91 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a twelve month low of $6.93 and a twelve month high of $23.79. The company’s 50 day moving average is $18.20 and its 200 day moving average is $18.27. The company has a market cap of $3.60 billion, a PE ratio of -247.79 and a beta of 1.67.

Oscar Health (NYSE:OSCR) last posted its earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). The business had revenue of $2.42 billion for the quarter, compared to analyst estimates of $2.33 billion. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The company’s revenue for the quarter was up 68.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.29) earnings per share. On average, sell-side analysts forecast that Oscar Health, Inc. will post -0.01 EPS for the current year.

Insider Transactions at Oscar Health

In related news, CFO Richard Scott Blackley sold 68,978 shares of the firm’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $1,240,914.22. Following the sale, the chief financial officer now owns 884,213 shares in the company, valued at approximately $15,906,991.87. This trade represents a 7.24 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Thrive Partners Vii Growth Gp, acquired 420,819 shares of the business’s stock in a transaction on Tuesday, November 12th. The stock was purchased at an average cost of $13.68 per share, with a total value of $5,756,803.92. Following the acquisition, the director now directly owns 5,452,081 shares of the company’s stock, valued at $74,584,468.08. This represents a 8.36 % increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders have purchased 1,055,478 shares of company stock worth $14,432,852 and have sold 169,569 shares worth $3,007,069. Company insiders own 25.11% of the company’s stock.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.